Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,824 products)
- Apoptosis(6,303 products)
- Cell Cycle/Checkpoint(4,862 products)
- Chromatin/Epigenetics(2,607 products)
- Cytoskeletal Signaling(1,553 products)
- DNA Damage/DNA Repair(2,875 products)
- Endocrinology/Hormones(3,752 products)
- Enzyme(3,671 products)
- GPCR/G-Protein(8,998 products)
- Immunology and Inflammation(3,861 products)
- Influenza Virus(300 products)
- JAK/STAT signaling(416 products)
- MAPK Signaling(1,253 products)
- Membrane Transporter/Ion Channel(3,155 products)
- Metabolism(10,145 products)
- Microbiology/Virology(7,618 products)
- Neuroscience(10,355 products)
- Other Inhibitors(35,866 products)
- Oxidation-Reduction(40 products)
- PI3K/Akt/mTOR Signaling(1,426 products)
- Proteases/Proteasome(1,687 products)
- Stem Cell and Derivatives(737 products)
- Tyrosine Kinase/Adaptors(1,976 products)
- Ubiquitination(1,726 products)
Show 16 more subcategories
Found 66549 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
PLP_Snyder530
PLP_Snyder530, a potent PL pro inhibitor, halts SARS-CoV-2 by triggering protease conformation changes.Formula:C24H24N2O2Color and Shape:SolidMolecular weight:372.46HDAC6-IN-3
HDAC6-IN-3 (Compound 14) is an oral anti-prostate cancer agent, inhibiting HDACs and MAO-A, with IC50 of 0.02-1.54 μM.Formula:C19H27N3O3Color and Shape:SolidMolecular weight:345.44NMDAR/HDAC-IN-1
Compound 9d is a dual NMDAR and HDAC inhibitor with high NMDAR affinity (Ki=0.59 μM) and inhibits HDAC1-3,6,8; crosses the blood-brain barrier.Formula:C22H28N2O3Color and Shape:SolidMolecular weight:368.47Terpendole E
CAS:Terpendole E is an atypical L5 site inhibitor.Formula:C28H39NO3Color and Shape:SolidMolecular weight:437.61GID4 Ligand 2
GID4 Ligand 2 (compound 67) is a selective binder for GID4 with IC50 of 18.9 μM and Kd of 17 μM. GID4 Ligand 2 can be used for the synthesis of PROTACs [1].Formula:C15H16N2Color and Shape:SolidMolecular weight:224.3Anti-inflammatory agent 10
Tilomisole-derived benzimidazole-thiazole, orally active, favors COX-2 inhibition over COX-1.Formula:C17H13BrN4O3S2Color and Shape:SolidMolecular weight:465.34PARP10/15-IN-3
Compound 8a, a dual PARP10 & PARP15 inhibitor, has IC50s: PARP10 at 0.14μM & PARP15 at 0.40μM; it's cell-permeable & anti-apoptotic.Formula:C12H12N2O3Color and Shape:SolidMolecular weight:232.24PIM1-IN-3
PIM1-IN-3 (HL8) selectively blocks PIM1, induces Colo320 cell apoptosis, and may be researched for cancer.Formula:C27H25BrN6OColor and Shape:SolidMolecular weight:529.43ZLWT-37
ZLWT-37: Oral CDK inhibitor, CDK9 IC50=0.002 µM, CDK2 IC50=0.054 µM; halts HCT116 cells at G2/M, induces apoptosis.Formula:C26H30ClN5OColor and Shape:SolidMolecular weight:464HIV-1 inhibitor-52
CAS:HIV-1 inhibitor-52: potent, broad-spectrum with EC50s 1.6-6.4 nM against various HIV-1 strains.Formula:C46H72FNO5SColor and Shape:SolidMolecular weight:770.13MRGPRX1 agonist 3
Compound 1f, a potent MRGPRX1 agonist, has an EC50 of 0.22 μM, useful for neuropathic pain studies.Formula:C14H11FN2OSColor and Shape:SolidMolecular weight:274.31HER2-IN-10
HER2-IN-10 is a psoralen derivative that induces apoptosis. HER2-IN-10 shows anti-breast cancer activity and light-activated cytotoxicity [1].Formula:C15H13NO5Color and Shape:SolidMolecular weight:287.27Everafenib
Everafenib: potent BRAF inhibitor, crosses blood-brain barrier, hinders MAPK, effective on V600EBRAF cells, outperforms other drugs in trials.Formula:C20H23ClFN5O2S2Color and Shape:SolidMolecular weight:484.01CBP/p300-IN-16
CBP/p300-IN-16 (compound 1) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.61 μM) and LK2 H3K27 (IC50: 2.24 μM).Formula:C26H31N3O4Color and Shape:SolidMolecular weight:449.54FGFR4-IN-6
FGFR4-IN-6: covalent, reversible FGFR4 blocker, 5.4 nM IC50, good oral bioavailability, reduces Hep3B2.1-7 tumors in mice, low toxicity.Formula:C31H33N7O4Color and Shape:SolidMolecular weight:567.64LX2761
CAS:LX2761 is a stable inhibitor for SGLT1/2 with IC50s of 2.2/2.7 nM; it targets SGLT1 in the GI tract.Formula:C32H47N3O6SPurity:98%Color and Shape:SolidMolecular weight:601.80Antifungal agent 42
Antifungal 42 blocks biofilm formation and inhibits C.albicans' CYP51.Formula:C22H20Cl2N4Se2Color and Shape:SolidMolecular weight:569.25MTL-CEBPA
MTL-CEPBA is a small activating RNA that targets C/EBPα upregulation and exhibits anti-inflammatory and anti-cancer effects.Color and Shape:SolidNamitecan
CAS:Namitecan is an effective inhibitor of topoisomerase I. It has antitumor property.Formula:C23H22N4O5Purity:98%Color and Shape:SolidMolecular weight:434.44JAK2/FLT3-IN-1 TFA
JAK2/FLT3-IN-1 (TFA), an oral JAK2/FLT3 inhibitor, shows anticancer properties; IC50: JAK2 (0.7 nM), FLT3 (4 nM), JAK1 (26 nM), JAK3 (39 nM).Formula:C27H35F4N7O3Color and Shape:SolidMolecular weight:581.61
